choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Rhenium

Rhenium Newsletter
  • Optimizing Rhenium Re 186 Obisbemeda Dosing for Leptomeningeal Metastases 03 Jul 2025 01:34 GMT

    … dose optimization trial for rhenium Re 186 obisbemeda (Reyobiq) … the dosing regimen for [rhenium Re 186 obisbemeda] in … potent radiation delivery envisioned for rhenium Re 186 obisbemeda, aiming … of multiple doses of rhenium Re 186 obisbemeda administered …

  • Efficacy Seen in Leptomeningeal Disease With Rhenium Obisbemeda Therapy 24 Jun 2025 02:54 GMT

    While results showed that rhenium obisbemeda improved survival and had … . Transcript: We are also studying [rhenium obisbemeda] in leptomeningeal disease. In … al. Convection enhanced delivery of Rhenium (186Re) Obisbemeda (186RNL) in recurrent …

  • Rhenium Obisbemeda Shows No DLTs and Improves Survival in Recurrent Glioma 22 Jun 2025 23:06 GMT

    … ReSPECT-GBM trial (NCT01906385) evaluating rhenium obisbemeda in patients with recurrent … ReSPECT-GBM trial (NCT01906385) evaluating rhenium obisbemeda in patients with recurrent … al. Convection enhanced delivery of Rhenium (186Re) Obisbemeda (186RNL) in …

  • Rhenium Obisbemeda Maintains and Distributes Radioisotopes in Glioma 21 Jun 2025 19:57 GMT

    … . During the conversation, he compared rhenium obisbemeda to doxorubicin liposomal and … Center at San Antonio. Transcript: Rhenium obisbemeda is a liposomal-encapsulated … al. Convection enhanced delivery of Rhenium (186Re) Obisbemeda (186RNL) in recurrent …

  • Rhenium Obisbemeda Improves Survival in Recurrent Glioblastoma 30 May 2025 20:59 GMT

    … Antonio, spoke with CancerNetwork®, regarding rhenium obisbemeda and the results from … mechanism of action of rhenium obisbemeda? Brenner: Rhenium obisbemeda is a liposomal … disease? We are also studying [rhenium obisbemeda] in leptomeningeal disease. In …

  • Rhenium (Re186) Obisbemeda Shows Initial Safety, Clinical Benefit in Leptomeningeal Metastases 15 May 2025 14:38 GMT

    Single-dose rhenium (Re186) obisbemeda (Reyobiq; 186RNL) was … , D’Amico R, et al. Rhenium obisbemeda (Reyobiq) in leptomeningeal metastases … ; Vienna, Austria. Intraventricular administration of rhenium-186 nanoliposome for leptomeningeal metastases …

  • Rhenium extraction from Kuril volcano gas may start in 24 months 16 Apr 2025 10:31 GMT

    … Pilot-scale extraction of rhenium and other rare metals for … the world’s only commercial rhenium deposit — the Kudryavy … of investors in the Russian Rhenium project Maxim Korobov said. … quot; Korobov noted. Besides rhenium, the initiative also includes the …

  • Iran breaks Germany's monopoly on cancer-treating Rhenium-188 10 Apr 2025 19:53 GMT

    … the world to commercially produce Rhenium-188, a radioactive isotope used … a new skin cream containing Rhenium-188 (Re-188) that … for treating common skin cancers. Rhenium-188 is a high-energy … the sole commercial producer of Rhenium-188, but on Wednesday, …

  • Rhenium: A Rare Metal with High-Value Applications 01 Apr 2025 23:53 GMT

    … to its unique characteristics, rhenium plays a crucial role in … drive interest in rhenium. Properties and Characteristics Rhenium (Re) is … At 3,180°C, rhenium has one of the highest … . Applications of Rhenium Aerospace & Jet Engines Rhenium is a critical …

  • FDA Grants Orphan Drug Designation to Rhenium (186Re) Obisbemeda for Leptomeningeal Metastases in Lung Cancer 12 Mar 2025 20:53 GMT

    … designation to the investigational radiotherapeutic rhenium (186Re) obisbemeda as a … “Receiving orphan drug designation for rhenium (186Re) obisbemeda marks a … plus-therapeutics-advances-lead-drug-rhenium-186re-obisbemeda Intraventricular administration …

Satisfied with the content?

Continue to create your account.